Three grants to diabetes doctor
Medical doctor at AU and AUH, Esben Søndergaard, will receive three grants towards research into type 2 diabetes.
Esben Søndergaard conducts research into a new form of treatment for type 2 diabetes which reduces the risk of heart disease and renal failure in people with type 2 diabetes. An extensive new study has shown that treatment with what are known as SGLT-2 inhibitors reduces the risk of death from heart failure and renal disease. The aim of the research is to map out the positive effects of the treatment and – in the long term – to contribute to a more targeted treatment of people with type 2 diabetes.
Esben Søndergaard has received three grants in total: DKK 368,482 from the Health Science Research Foundation of the Central Denmark Region; DKK 383,705 from the Danish Council for Independent Research; and DKK 968,543 from the Novo Nordisk Foundation. Esben Søndergaard sees the grants as a recognition of his work.
Contact
MD, PhD, Esben Søndergaard
Aarhus University, Department of Clinical Medicine and
Aarhus University Hospital, Department of Endocrinology and Internal Medicine
Email: esben.sondergaard@clin.au.dk
Tel. (+45) 7846 1631